112 related articles for article (PubMed ID: 8338792)
1. 19-Oxoandrost-4-ene-3,17-dione amplifies the action of aldosterone.
Sekihara H; Yazaki Y
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):69-72. PubMed ID: 8338792
[TBL] [Abstract][Full Text] [Related]
2. 19-norandrost-4-ene-3, 17-dione amplifies the action of aldosterone only in sodium-loaded conditions: evidence for a new class of amplifiers of aldosterone.
Sekihara H; Ohsawa N; Kosaka K
Biochem Biophys Res Commun; 1980 Mar; 93(2):495-500. PubMed ID: 7387654
[No Abstract] [Full Text] [Related]
3. Amplification of the action of subthreshold doses of aldosterone by 19-hydroxyandrost-4-ene-3, 17-dione.
Sekihara H; Ohsawa N; Kosaka K
Biochem Biophys Res Commun; 1979 Apr; 87(3):827-35. PubMed ID: 454430
[No Abstract] [Full Text] [Related]
4. 19-Hydroxyandrostenedione amplifies the hypertensive action of mineralocorticoids in rats.
Sekihara H; Yazaki Y; Kojima T
J Endocrinol; 1993 Jul; 138(1):31-40. PubMed ID: 7852890
[TBL] [Abstract][Full Text] [Related]
5. 6 beta-hydroxy-4-androstene-3,17-dione: a potent amplifier of the kaliuretic action of aldosterone.
Sekihara H; Ohsawa N; Kosaka K
J Steroid Biochem; 1981 Apr; 14(4):327-9. PubMed ID: 7230795
[No Abstract] [Full Text] [Related]
6. 19-Hydroxyandrostenedione: evidence for a new class of sodium-retaining and hypertensinogenic steroids.
Sekihara H
Endocrinology; 1983 Sep; 113(3):1141-8. PubMed ID: 6347666
[TBL] [Abstract][Full Text] [Related]
7. 5 alpha-Dihydro-11-deoxycorticosterone as a mineralocorticoid agonist and antagonist: evidence for a weak mineralocorticoid as an antagonist of potent mineralocorticoids.
Sekihara H; Yazaki Y
J Steroid Biochem Mol Biol; 1993 Apr; 45(4):235-8. PubMed ID: 8499332
[TBL] [Abstract][Full Text] [Related]
8. 6 beta-Hydroxyandrostenedione: evidence for a new hypertensinogenic agent.
Sekihara H
Clin Exp Hypertens A; 1983; 5(1):1-9. PubMed ID: 6339119
[TBL] [Abstract][Full Text] [Related]
9. Ouabain causes kaliuresis and works synergistically with aldosterone in vivo.
Sekihara H; Yazaki Y
Life Sci; 1993; 53(12):975-80. PubMed ID: 8361328
[TBL] [Abstract][Full Text] [Related]
10. Amplification of mineralocorticoid activity of aldosterone by 18-hydroxy-corticosterone and 18-hydroxy-19-nor-corticosterone in adrenalectomized rats.
Rosenthal T; Shani M; Peleg E; Harnik M
Endocr Res; 1990; 16(2):185-91. PubMed ID: 2344835
[TBL] [Abstract][Full Text] [Related]
11. 19-Hydroxyandrostenedione: a potent hypertensinogenic steroid in man.
Sekihara H
J Steroid Biochem; 1983 Jul; 19(1A):353-8. PubMed ID: 6310235
[TBL] [Abstract][Full Text] [Related]
12. A reevaluation of the mineralocorticoid and hypertensinogenic potential of 19-hydroxyandrostenedione.
Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 1986 Jun; 118(6):2582-7. PubMed ID: 3698922
[TBL] [Abstract][Full Text] [Related]
13. Effect of aldosterone on urinary kallikrein and prostaglandin excretion in the rat.
Fejes-Tóth G; Náray-Fejes-Tóth A
J Physiol; 1984 Sep; 354():79-88. PubMed ID: 6592330
[TBL] [Abstract][Full Text] [Related]
14. Effects of mineralocorticoids on Na+ and K+ excretion in the adrenalectomized rat.
Horisberger JD; Diezi J
Am J Physiol; 1983 Jul; 245(1):F89-99. PubMed ID: 6869541
[TBL] [Abstract][Full Text] [Related]
15. Interaction of aldosterone and oxytocin to influence renal sodium excretion in rats.
Musabayane CT; Ndhlovu CE; Forsling ML; Balment RJ
Exp Physiol; 1994 Sep; 79(5):763-74. PubMed ID: 7818865
[TBL] [Abstract][Full Text] [Related]
16. Progestogens with antimineralocorticoid activity.
Losert W; Casals-Stenzel J; Buse M
Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
[TBL] [Abstract][Full Text] [Related]
17. 19-hydroxyandrostenedione as a new hypertensinogenic agent.
Sekihara H
J Steroid Biochem; 1982 Feb; 16(2):329-31. PubMed ID: 7043093
[TBL] [Abstract][Full Text] [Related]
18. Modulation of renal sodium-potassium-adenosine triphosphatase by aldosterone. Effect of high physiologic levels on enzyme activity in isolated rat and rabbit tubules.
Mujais SK; Chekal MA; Jones WJ; Hayslett JP; Katz AI
J Clin Invest; 1985 Jul; 76(1):170-6. PubMed ID: 2991336
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid inhibition of mineralocorticoid action in the rat.
Kenyon CJ; Saccoccio NA; Morris DJ
Clin Sci (Lond); 1984 Sep; 67(3):329-35. PubMed ID: 6380888
[TBL] [Abstract][Full Text] [Related]
20. Interaction between aldosterone and renomedullary prostaglandins. Competitive action between aspirin and spironolactone.
Papanicolaou N; Lefkos N; Massourides E; Marketos S; Papavassiliou J; Bariety J; Milliez P
Experientia; 1977 Dec; 33(12):1632-4. PubMed ID: 590459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
